Trial Profile
A Double-Blind, Placebo-Controlled Random Order Crossover Study of Iloperidone for Symptoms of Arousal in PTSD Including Insomnia and Irritability.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2020
Price :
$35
*
At a glance
- Drugs Iloperidone (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 21 Jan 2020 Status changed from completed to discontinued.
- 25 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Aug 2013 New trial record